| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-828 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
1991-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d46da70a55724cd727fa42e39bbba6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8afd302265c827f5ef53bd4f0727d23d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5431e65bb00d056127ca6bae6b1f87b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7b5473465798a57a122fbca50a32f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cfdade63913f2e86ae6d6774ec0f464 |
| publicationDate |
1993-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0536215-A1 |
| titleOfInvention |
Neurofibromatosis gene |
| abstract |
We have identified, cloned and sequenced the entire coding region of the gene involved in von Recklinghausen's neurofibromatosis (NF1) as well as a large transcript (NF1LT) expressed in a ubiquitous manner in the gene. Through the identification of the NF1 gene and its genetic product, nucleic acid probes and antibodies developed against the genetic product can be used in a variety of hybridization and immunological assays, in order to conduct research NF1 and detect it in its first manifestations. We can also develop conventional and genetic therapies to treat people with the disease. |
| priorityDate |
1990-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |